MAHP responds to U.S. Department of Health and Human Services proposal to increase drug price transparency in Medicaid

MAHP responds to U.S. Department of Health and Human Services proposal to increase drug price transparency in Medicaid

LANSING, MI – Dominick Pallone, executive director of the Michigan Association of Health Plans, responds to the U.S. Department of Health and Human Services prescription drug price transparency in Medicaid:
“The federal government took bold action to hold drug manufacturers accountable for their unsustainable and unsubstantiated prescription drug pricing. The Michigan Association of Health Plans applauds these actions and encourages Michigan policymakers to follow suit and pass HB 4409.”

###

The Michigan Association of Health Plans (MAHP) is an industry voice for 11 health care plans, covering more than 3.1 million Michigan residents, and 50 businesses affiliated with the health care industry. MAHP facilitates communication among members, government, and the industry regarding health care issues of common concern. The mission of the Michigan Association of Health Plans is to provide leadership for the promotion and advocacy of high quality, affordable, accessible health care for the citizens of Michigan.

  back to blog